Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways.
Saved in:
| Title: | Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways. |
|---|---|
| Authors: | Wang X; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. wangxianping@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. wangxianping@westlake.edu.cn., Guo Y; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Lin P; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Yu M; Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Song S; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Xu W; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Kong D; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Wang Y; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.; Department of Diabetes & Cancer Metabolism, Beckman Research Institute of City of Hope National Medical Center, Duarte, CA, 91010, USA., Zhang Y; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Lu F; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China., Xie Q; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. xieqi@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. xieqi@westlake.edu.cn., Ma X; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. maxianjue@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. maxianjue@westlake.edu.cn. |
| Source: | The EMBO journal [EMBO J] 2024 Dec; Vol. 43 (24), pp. 6336-6363. Date of Electronic Publication: 2024 Nov 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
